PerkinElmer Buys VisEn Medical | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer today said it has acquired VisEn Medical for an undisclosed amount.

In a statement, PerkinElmer said that the purchase of the in vivo molecular imaging technology firm will enhance its cellular imaging business by "expanding [its] technologies and capabilities downstream into preclinical research undertaken in academic institutes and pharmaceutical companies."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.